diabetes header graphic


Foot Problems In Diabetics
By Alan Davis
Diabetes is an ailment caused by the lack of insulin production due to failure of insulin production, or the inability of insulin to function regularly in its everyday performance. Insulin is a substance which the pancreas glands process from our food to turn into energy.

Approximately, there are 16 million Americans who are affected with 2 types of diabetes. Type 1 is often connected with juvenile and frequently linked to heredity. Type 2, however, is usually referred to as adult onset diabetes. It is distinguished by high blood sugar, or people who are overweight.

There are many complications that are associated with diabetes. It suspends the vascular system and affects many areas of the body such as the eyes, kidneys, legs and especially, the feet.

25% of the 16 million Americans diagnosed with often develop foot problems. Poor blood circulation and neuropathy cause numbness or loss of feeling of pain, heat or cold. Usually a diabetic who suffers from neuropathy suffers minor cuts, scrapes and blisters that he may not be aware of due to insensitivity. These injuries may lead to complications such as ulceration and even amputation. Neuropathy may cause bunions and hammer toes or other related foot deformities.

Diabetes frequently leads to vascular disease that slows the blood circulation. Contraction of the arteries decreases circulation



over the lower part of a body, such as the feet and lower part of the legs. Reduced circulation adds up to diabetic foot problem because of lack of oxygen and nutrition supplied to the skin, and tissue leading to poor healing of an injury. It also leads to swelling and drying of the foot. Ulcers, infections and other serious foot injuries are more critical for a diabetic due to poor circulation that impairs the healing process. In a diabetic, footwear plays an important role.

It is a must for a diabetic to take precautions for preventing foot injuries. Diabetics must observe and take extra concern to reduce the risk of serious foot injuries due to neuropathy.

Since it is a necessity for a diabetic to take preventive measures, he must keep his feet healthy and free from harm. If you are a diabetic and may be suffering from foot problems, consult your foot doctor right away.

Proper care of feet is essential for diabetics because of being prone to foot problems such as foot deformities, foot ulcers, loss of feeling, and foot injuries that do not heal.

According to the National Institute of Health, there are a few simple ways to follow in preventing serious complications from diabetes. Keep a healthy lifestyle and follow a healthy diet, keep your blood sugar close to normal, check your feet for cuts, sores, red spots, swellings, and cuts that do not heal, wash your feet with warm water daily, wear socks at all times, protect your bare feet from extreme temperatures such as extremes of heat and cold, keep your blood circulating to your feet, being active, exercise regularly, and communicate with your doctor.

Alan Davis is the master product formulator at www.outsidehealth.net and has developed quite a few products to help with diabetic foot problems including an assortment of creams and lotion that stimulate and repair skin on the feet.




Here are some more diabetes articles...

Choose The Right Foods To Lower Your Blood Sugar Levels
By Julia Hanf
Diabetes is a condition that millions of people manage on a daily basis. People with diabetes must be mindful of the foods and beverages they consume. Whether or not you have had natural diabetes Read more...
Absolutely The Best Way To Lose Weight Fast
By Stephen
Once you are diagnosed that you have an illness like diabetes, it can be hard on you emotionally and mentally to face it. But, since it is there already, this time, you want to take control of Read more...

Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes
<b>Conditions</b>:   Type 1 Diabetes;   Hypertension<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   Steno Diabetes Center<br/><b>Recruiting</b> - verified April 2010
A Study on the Prevalence of Obstructive Sleep Apnea in Patients With Type II Diabetes Mellitus
<b>Conditions</b>:   Obstructive Sleep Apnea;   Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   The University of Hong Kong<br/><b>Completed</b> - verified July 2010
Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus
<b>Condition</b>:   Diabetic Macular Edema<br/><b>Interventions</b>:   Drug: Ranibizumab;   Drug: ranibizumab;   Drug: ranibizumab<br/><b>Sponsor</b>:   Novartis Pharmaceuticals<br/><b>Not yet recruiting</b> - verified July 2010
To Evaluate if Wide Glucose Fluctuations Lead to Injury of Heart Nerves
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   University of Michigan<br/><b>Recruiting</b> - verified May 2010
Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I)
<b>Conditions</b>:   Vascular Diseases;   Diabetes<br/><b>Interventions</b>:   Device: femoral-popliteal bypass;   Device: stent<br/><b>Sponsors</b>:   Peking Union Medical College Hospital;   Beijing Tongren Hospital;   Xuanwu Hospital, Beijing<br/><b>Not yet recruiting</b> - verified July 2010
Comparing Safety and Efficacy of NN5401 With Insulin Glargine in Subjects With Type 2 Diabetes: An Extension to Trial NN5401-3590
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN5401;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Recruiting</b> - verified July 2010
Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: LIXISENATIDE (AVE0010);   Drug: Placebo<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Recruiting</b> - verified July 2010
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vitamin D3;   Drug: Placebo<br/><b>Sponsor</b>:   King Faisal Specialist Hospital & Research Center<br/><b>Not yet recruiting</b> - verified July 2010
Does Vitamin D Improve Glycemic Control in Type II DM?
<b>Conditions</b>:   Diabetes Mellitus;   Vitamin D Deficiency<br/><b>Interventions</b>:   Drug: vitamin D3 2000 IU;   Drug: vitamin D3 5000 IU;   Drug: Placebo<br/><b>Sponsor</b>:   King Faisal Specialist Hospital & Research Center<br/><b>Not yet recruiting</b> - verified July 2010
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes
<b>Conditions</b>:   Diabetes;   Insulin<br/><b>Intervention</b>:   Device: insulin dose software<br/><b>Sponsors</b>:   Park Nicollet Institute;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Hygieia, Inc;   International Diabetes Center at Park Nicollet<br/><b>Recruiting</b> - verified June 2010
Type 2 Diabetes and Obesity in Mexican Pimas: Gene-Environment Interaction
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified June 2010
Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   Drug: Insulin Glargine<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified July 2010
A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: SK-0403;   Drug: Placebo;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Kowa Research Institute, Inc.<br/><b>Not yet recruiting</b> - verified June 2010
Tu Salud Si Cuenta: UT Community Outreach Program for Community-based Diabetes Prevention and Control.
<b>Condition</b>:   Diabetes, Obesity<br/><b>Intervention</b>:   Behavioral: Tu Salud Si Cuenta Behavioral Intervention<br/><b>Sponsor</b>:   The University of Texas Health Science Center, Houston<br/><b>Recruiting</b> - verified July 2010
Hypothalamic Function Before and After Bariatric Surgery
<b>Conditions</b>:   Obesity;   Diabetes<br/><b>Interventions</b>:   Procedure: Roux en Y gastric bypass and lap. gastric banding;   Behavioral: Prodimed dietary intervention<br/><b>Sponsor</b>:   Leiden University Medical Center<br/><b>Recruiting</b> - verified January 2010
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
<b>Conditions</b>:   Diabetic Retinopathy;   Diabetic Macular Edema<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   National Eye Institute (NEI)<br/><b>Recruiting</b> - verified July 2010
Psoriasis Inflammation and Systemic Co Morbidities
<b>Condition</b>:   Psoriasis<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Rockefeller University;   Weill Medical College of Cornell University<br/><b>Recruiting</b> - verified July 2010
The Effectiveness of Lubiprostone in Constipated Diabetics
<b>Conditions</b>:   Constipation;   Diabetes;   Colon Transit<br/><b>Intervention</b>:   Drug: Lubiprostone<br/><b>Sponsor</b>:   Emory University<br/><b>Not yet recruiting</b> - verified July 2010
Noninvasive Transcutaneous Glucometer Development
<b>Conditions</b>:   Healthy;   Prediabetic State (IGT);   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   <br/><b>Sponsor</b>:   InLight Solutions<br/><b>Completed</b> - verified February 2008
Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral Regurgitation
<b>Conditions</b>:   Mitral Valve Insufficiency;   Atrial Fibrillation;   Heart Failure<br/><b>Intervention</b>:   Procedure: Cardiac catheterization<br/><b>Sponsors</b>:   Kaohsiung Veterans General Hospital.;   National Science Council, Taiwan<br/><b>Recruiting</b> - verified June 2010
Comprehensive Analyses of Multidetector-row Cardiac Computed Tomography Data in Koreans
<b>Condition</b>:   Coronary Disease<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Seoul National University Bundang Hospital;   The Korean Society of Lipidology and Atherosclerosis<br/><b>Recruiting</b> - verified June 2010
Effect of Recombinant Human Growth Hormone (rhGH) Administration on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Adolescent Girls
<b>Condition</b>:   Obesity<br/><b>Interventions</b>:   Drug: recombinant human growth hormone (rhGH);   Drug: Placebo<br/><b>Sponsors</b>:   Massachusetts General Hospital;   Genentech<br/><b>Recruiting</b> - verified July 2010
Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: Dapagliflozin<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Not yet recruiting</b> - verified July 2010
Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease.
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Drug: Glucobay (Acarbose, BAYG5421)<br/><b>Sponsor</b>:   Bayer<br/><b>Completed</b> - verified July 2010
Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: insulin aspart;   Drug: insulin detemir;   Drug: insulin aspart;   Drug: insulin detemir<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified July 2010
Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans
<b>Condition</b>:   Type II Diabetes Mellitus<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Arizona State University;   Takeda Pharmaceuticals North America, Inc.<br/><b>Recruiting</b> - verified July 2010
Vitamin D in Vulnerable Adults
<b>Conditions</b>:   Frail Elderly;   Vitamin D Deficiency<br/><b>Interventions</b>:   Dietary Supplement: vitamin D;   Dietary Supplement: placebo<br/><b>Sponsor</b>:   Department of Veterans Affairs<br/><b>Not yet recruiting</b> - verified July 2010
Left Atrial Distensibility and Left Ventricular Filling Pressure in Acute Myocardial Infarction
<b>Condition</b>:   Myocardial Infarction<br/><b>Intervention</b>:   Procedure: Primary percutaneous coronary intervention<br/><b>Sponsors</b>:   Kaohsiung Veterans General Hospital.;   No other funding source in this study<br/><b>Completed</b> - verified December 2007
Use of Bevacizumab in Trabeculectomy Surgery
<b>Conditions</b>:   Glaucoma;   Optic Neuropathy;   Fibrosis<br/><b>Interventions</b>:   Drug: Bevacizumab;   Drug: Control<br/><b>Sponsors</b>:   Sunnybrook Health Sciences Centre;   Glaucoma Research Society of Canada<br/><b>Recruiting</b> - verified July 2010
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
<b>Conditions</b>:   Coronary Artery Disease;   Stents;   Coronary Thrombosis<br/><b>Interventions</b>:   Device: coronary stent placement;   Device: Coronary stent placement;   Device: coronary stent placement<br/><b>Sponsor</b>:   University Hospital, Basel, Switzerland<br/><b>Recruiting</b> - verified July 2010
Establishment of Biomarkers for Fabry Disease
<b>Condition</b>:   Fabry Disease<br/><b>Intervention</b>:   Other: Fluorescein angiography<br/><b>Sponsors</b>:   Ohio State University;   Genzyme<br/><b>Not yet recruiting</b> - verified July 2010
The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) Study
<b>Conditions</b>:   Infant;   Obesity<br/><b>Interventions</b>:   Behavioral: Child Safety Insights;   Behavioral: Child Feeding Insights<br/><b>Sponsors</b>:   Penn State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Not yet recruiting</b> - verified July 2010
Anticholinergic vs. Botox Comparison Study
<b>Conditions</b>:   Urge Urinary Incontinence;   Overactive Bladder Syndrome<br/><b>Interventions</b>:   Drug: Botulinum toxin A (Botox A®);   Drug: Solifenacin 5mg;   Drug: Solifenacin 10mg;   Drug: Trospium chloride<br/><b>Sponsors</b>:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Office of Research on Women's Health (ORWH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified June 2010
Reducing Dietary Energy Density by Incorporating Vegetables in Order to Decrease Energy Intake
<b>Condition</b>:   Obesity<br/><b>Intervention</b>:   Other: Incorporating vegetables into the diet to reduce energy density<br/><b>Sponsors</b>:   Penn State University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Active, not recruiting</b> - verified July 2010